Abstract-High-resolution magnetic resonance imaging (MRI) with flow suppression not only provides useful information on luminal and wall areas of the carotid artery but also can identify the principal tissue components of the carotid atherosclerotic plaque. The effects of intensive lipid-lowering therapy on these MRI tissue characteristics were examined in patients with coronary disease (CAD Key Words: MRI Ⅲ atherosclerotic plaque Ⅲ lipid-lowering therapy P athological studies 1,2 of acute coronary syndromes have shown that erosion or rupture of a single coronary plaque, with superimposed thrombosis and vasospasm, is the principal mechanism precipitating ischemia. Histological studies of these culprit lesions have shown that the majority of ruptured plaques contain a soft lipid-rich core that is covered by a thin cap of fibrous tissue infiltrated by foam cells. [1] [2] [3] [4] In the past 2 decades, numerous clinical 5-7 and angiographic 5 studies have demonstrated that lipid-lowering therapy is effective in the primary and secondary prevention of cardiovascular events and induces angiographic regression in Ϸ12% of coronary lesions. 8 The reduction in clinical events in these trials appears to be best explained by the effects of lipid-lowering therapy on the above high-risk features of plaque morphology. A hypothesis has been proposed: Lipid-lowering therapy selectively lipid-depletes (regresses) a relatively small but dangerous subgroup of vulnerable lesions containing a large lipid core and dense clusters of intimal macrophages. These lesions are thereby effectively stabilized, and the clinical event rate is accordingly decreased. 9 Although shown in experimental models, plaque lipid depletion remains to be confirmed in humans.
P athological studies 1,2 of acute coronary syndromes have shown that erosion or rupture of a single coronary plaque, with superimposed thrombosis and vasospasm, is the principal mechanism precipitating ischemia. Histological studies of these culprit lesions have shown that the majority of ruptured plaques contain a soft lipid-rich core that is covered by a thin cap of fibrous tissue infiltrated by foam cells. [1] [2] [3] [4] In the past 2 decades, numerous clinical [5] [6] [7] and angiographic 5 studies have demonstrated that lipid-lowering therapy is effective in the primary and secondary prevention of cardiovascular events and induces angiographic regression in Ϸ12% of coronary lesions. 8 The reduction in clinical events in these trials appears to be best explained by the effects of lipid-lowering therapy on the above high-risk features of plaque morphology. A hypothesis has been proposed: Lipid-lowering therapy selectively lipid-depletes (regresses) a relatively small but dangerous subgroup of vulnerable lesions containing a large lipid core and dense clusters of intimal macrophages. These lesions are thereby effectively stabilized, and the clinical event rate is accordingly decreased. 9 Although shown in experimental models, plaque lipid depletion remains to be confirmed in humans.
See cover and editorial, page 1563
Recent human and animal studies have suggested that MRI of atherosclerosis may provide information on plaque com-position as well as on plaque volume. 10 -15 The development of high-resolution MRI technique holds great promise for the evaluation of carotid atherosclerosis in vivo. 11, 15 In this cross-sectional case-control study, we sought to determine, by using MRI, whether hyperlipidemic patients with coronary artery disease (CAD) treated according to the recommendations of the National Cholesterol Education Program (NCEP) 16 over an extended period would have carotid plaque characteristics different from those of a comparable group of untreated CAD patients. Our findings support a major lipiddepleting effect of such therapy on the carotid plaque.
Methods

Patients
Eight male CAD patients who had been receiving intensive lipidlowering treatment (niacin 2.5 g/d, lovastatin 40 mg/d, and colestipol 20 g/d) for an average of 10 years in the Familial Atherosclerosis Treatment Study (FATS) follow-up 17 were selected at random from a group of 60 such patients and designated the treated group. All 8 patients had completed 10 years and were still active in treatment; as a group, their LDL averaged Ͻ100 mg/dL during the intensive treatment. Eight male CAD patients who were matched to the treated patients for age (Ϯ3 years), off-treatment LDL (Ϯ5 mg/dL), and triglycerides (Ϯ50 mg/dL) and who had never been treated with lipid-lowering drugs were selected as controls. The diagnosis of CAD was based on coronary angiography demonstrating at least one 50% stenosis or three 30% lesions. The 2 groups were identified before any MRI was performed.
MRI Scanning
Thirty-two carotid arteries in these 16 patients were examined. All of the images were obtained with a 1.5-T imager (SIGNA, Horizon Echo Speed 5.7, General Electric Medical Systems) with custommade bilateral carotid phased-array coils. 18 MRI time was 30 to 40 minutes per patient.
Fourteen consecutive levels (per artery) that were centered at the carotid bifurcation with 3-mm section thickness and no intersection gap and that covered Ϸ4-cm portions of the common carotid, bifurcation, and internal and external carotid arteries were scanned by using time-of-flight, T1, proton-density, and T2 weightings.
The MRI parameters used in the present study are listed in Table 1 .
Image Analysis
The image analyses were performed with the observers blinded to patient identity, treatment group, and clinical details. Images from 5 consecutive levels centered at carotid bifurcation, at 4 magnetic resonance (MR) weightings (see Table 1 ), were selected for detailed image analysis because plaque is more likely to develop near the carotid bifurcation.
Visual Assessment of Disease Severity and Complexity
Lesion morphology in these 20 images was visually classified into 5 types: (1) normal, (2) diffuse concentric thickening, (3) eccentric with luminal area greater than plaque area, (4) eccentric with luminal area smaller than plaque area, and (5) 
Identification of Carotid Atherosclerotic Plaque Components
The selected image from each carotid artery was traced, including the outer wall, lumen, and plaque morphological features. The latter were identified as subregions of the plaque with a relatively homogeneous gray scale for each weighting. See Figure 1 Echo train length
T1W, PDW, and T2W indicate T1-weighted, proton density-weighted, and T2-weighted images, respectively; TR, repetition time; and TE, echo time.
*Peripheral gating was used to suppress flow and motion artifacts in these relatively long TR/TE scans. Figure 1 . Example of plaque morphological feature analysis. The given MR image of a very complex plaque was traced according to protein-density (PD) weighting (PDW) because the PDW image showed the most plaque. Each identified and labeled morphological feature was then evaluated for contrast intensity from 4 different MR weightings by using a 16-level gray scale. T1 weighting (T1W) and PDW, 2 important contrast weightings for identifying tissue characteristics, were given in ths example. Feature 1 showed a common carotid arterial lumen with contrast level 15 on T1W and 16 on PDW. Feature 2 had contrast reading 2 on T1W and 1 on PDW; it was interpreted as fibrous tissue. Features 3, 6, and 7 had contrast reading 2 to 3 on T1W and 9 to 10 on PDW; these features were considered to be lipid content. Features 4 and 5 were graded at level 13 on T1W and 14 to 15 on PDW; these features were identified as calcium. Features 8 and 9 were graded at level 8 on T1W and 9 on PDW; they were likely to be lipid mixed with calcium.
Quantification of Carotid Luminal and Wall Areas and Plaque Components
The arterial outer wall and luminal areas were measured by planimetry with the use of NIH Image software. MRI does not distinguish readily between the fibrous tissue imaging characteristics of plaque and those of normal arterial media. As a consequence, our estimates of "plaque" area and composition include contributions from the thin rim of normal arterial media and, in reality, reflect "plaque plus media" estimates. Carotid plaque morphological features were identified visually, traced, and classified as 1 of the 4 components above, on the basis of the contrast pattern. These features, if identified, were each planimetered for area. Plaque area and the proportions of each plaque component were calculated. MRI examples of carotid plaque components from 2 control patients are shown in Figures 3 and 4 .
Statistical Analysis
The primary question addressed in this cross-sectional study was whether CAD patients exposed to prolonged intensive lipid-lowering therapy, compared with matched but untreated patients, would demonstrate different carotid plaque composition, as identified by MRI. Unpaired 2-tailed t tests were used to compare measurements from the 2 study groups, with level of PϽ0.05 considered significant.
Results
Patient Clinical and Lipid Characteristics
As shown in Table 3 , control and treated patients were comparable in terms of CAD risk and concomitant medication. However, compared with the control group lipid profile that was obtained before the MRI study, treated patients had significantly lower average on-treatment total cholesterol levels (228Ϯ14 [control] 
Interobserver Variability
Thirty-two images selected for greatest plaque size were analyzed by 2 independent observers (X.-Q.Z. and B.G.B.) for measurements of the outer arterial and luminal areas and plaque morphological composition. These measurements between the 2 observers were highly concordant. The correlation coefficients were rϭ0.84 (PϽ0.001) for the outer area measurement and 0.88 (PϽ0.001) for the luminal area. Estimates of lipid area were most concordant (rϭ0.93, PϽ0.001), with rϭ0.90 (PϽ0.001) for calcium. Because of its relative small proportion of plaque area, estimates for lipid mixed with calcium were not as well correlated (rϭ0.59, Figure 1 . Images from left to right are T1W, PDW, and T2 weighting (T2W). The arrowheads point to the calcification, which appears dark on all 3 contrast weightings. The arrows point to the lipid-rich region that appears very bright on T1W, dark on PDW, and darker on T2W.
PϽ0.001).
Because of a relatively narrow range of values for the contribution of fibrous tissue to plaque composition (50% to 90%), the estimates for the fibrous tissue were also not as well correlated (rϭ0.65, PϽ0.001).
Effects of Stenosis Severity on Plaque Tissue Characteristics
The sections selected for greatest plaque size in each carotid artery were classified into approximate tertiles of measured cross-sectional luminal area reduction: 26% to 50% (nϭ11), 51% to 65% (nϭ9), and 66% to 83% (nϭ12). There were no significant between-treatment group differences in this distribution.
As shown in Table 4 , the carotid wall area increased significantly when luminal area reduction became more severe. A trend of decreased fibrous tissue composition and of increased calcium and lipid mixed with calcium was observed with increasing luminal area reduction. Nonsignificant difference in lipid content was seen among the 3 tertiles of luminal area reduction; however, there was substantially less lipid among treated arteries in all 3 categories.
Between-Group Differences in Carotid Plaque Location and Obstruction
The carotid arteries from patients treated with intensive triple lipid-lowering therapy, compared with those from the matched controls, had a nonsignificant larger luminal area ( Table 5 . The most prominent carotid lesions were located in the common carotid in 53% of cases, at the bifurcation in 34%, and in the internal carotid arteries in 13%. There was no difference between the 2 groups. 
Between-Group Differences in Carotid Plaque Composition
Discussion
Our understanding of atherosclerotic plaque development and regression is derived largely from animal experiments. Studies of the nonhuman primate by Armstrong and Megan, 23, 24 Clarkson at al, 25 Small et al, 26 and Wissler and Vesselinovitch 27 have demonstrated convincing evidence that atherosclerotic plaque lipid content is depleted with plasma cholesterol reduction. When cholesterol-fed animals are changed to a vegetarian diet, plasma lipids fall quickly to 140 mg/dL, and the greatly increased arterial lipid content (principally cholesterol ester) decreases by 60% over 24 to 48 months. However, collagen content is only modestly (20%) reduced. 24, 25 In our case-control study, prolonged intensive lipid-lowering therapy is associated with strikingly reduced plaque lipid content (1% in treated versus 17% in control patients) and with only minor difference in fibrous tissue. Thus, the MRI-measured treatment group differences in human carotid plaque composition appear consistent with the known effects of therapy on plaque composition in nonhuman primates.
Atherosclerotic plaque characteristics play an important role in plaque instability 4,28 -31 ; the risk of plaque disruption with superimposed thrombosis is predicted by its lipid-related features, 28 such as the area of the core lipid region as a percentage of total plaque area 32 and foam cell cluster size in the fibrous cap and shoulder regions. 2,4,28 -31,33 The fibrous cap is also weakened by macrophage-associated stromelysin, one of a family of inflammatory matrix metalloproteinases. 34, 35 The extremely low plaque lipid composition (1%) among 8 CAD patients treated with intensive lipid-lowering therapy Use of aspirin, n (%) † 7 (88%) 5/7 (71%)
Use of ␤-blockers, n (%) † 1 (13%) 4/7 (57%)
Use of calcium channel blockers, n (%) † 0 1/7 (14%)
No statistically significant differences in the above variables were found between treated and matched control groups.
*For treated group, this is an off-treatment fasting lipid profile routinely obtained during the study; for the control group, this is the fasting lipid profile obtained at 1 to 3 months before the MRI study.
†Concomitant medication doses and duration were also similar. for 10 years was associated with a low rate (5%) of the composite end point: cardiac death or nonfatal myocardial infarction over 10 years of follow-up among the larger group of 60 patients, from whom these 8 were randomly chosen. 17 This encouraging result supports the idea that prolonged intensive lipid-lowering therapy will significantly decrease lipid composition in the plaque, an effect that would predict greater plaque stability and would thus reduce clinical ischemic events. Prospective studies are presently under way in randomized controlled trials to further test the hypothesis that intensive lipid-lowering therapy depletes plaque lipid and to examine the time course of such depletion and the relationship between plaque lipid depletion and change in other plaque components or plaque size (regression). Our understanding of human plaque composition is mainly from histological studies. The Roberts group 36 -40 has studied human coronary plaque composition in the spectrum of clinical atherosclerosis. Others 31, 41, 42 have studied aortic and carotid plaques. Our assessments of carotid fibrous tissue and calcium and lipid deposits with the use of MRI in vivo are consistent with previously reported histological findings. 41, 42 In a coronary plaque study, 37 91%, 82%, and 73% of coronary plaque area was fibrous tissue identified by histology for plaque with postmortem luminal narrowing of 26% to 50%, 51% to 75%, and 76% to 95%, respectively. In the present study, 86%, 82%, and 74% of the carotid plaque area was identified by MRI as fibrous tissue for plaques with in vivo luminal area reduction of 26% to 50%, 51% to 65%, and 66% to 83% stenosis, respectively. We saw a trend of increased calcium content with increasing luminal narrowing in carotid plaques, and the Roberts group (Kragel and colleagues 36, 37 ) has demonstrated the same phenomena in the coronary plaques. Furthermore, our measured lipid content, 17% by MRI, from the control patients was also similar to pultaceous debris plus foam cells and foam cells with lymphocytes (12% to 14% in coronary plaques by histology). 36, 37 Ex vivo MRI was recently found to identify lipid-rich core and fibrocellular lipid with a high level of sensitivity and specificity. 43 These data suggest that carotid plaque composition may have important potential to serve as a surrogate marker for coronary plaque composition.
To study the effects of lipid-lowering therapy on human atherosclerotic plaque size and composition in vivo, an imaging technique is needed that can characterize the crosssectional morphology and composition of the atherosclerotic arterial wall. MRI is ideal for longitudinal studies of atherosclerotic arteries because it is noninvasive and is superior to other imaging modalities in discriminating soft tissue contrast. 10 -14,19,20,44 -46 With current technology, the carotid application illustrated in the present study appears most promising. For widespread use, the speed of these measurements and their variability must be improved. Currently under development in our laboratory is an automated MRI analysis system that should provide accurate and more reproducible quantification of arterial luminal and wall areas and of the various tissue components and that will make image analysis more objective and less tedious.
In summary, the noninvasive analysis of carotid plaque in vivo by MRI provides an opportunity for longitudinally assessing changes in atherosclerotic lesions and, in particular, their tissue composition. Such studies appear to have great potential for more meaningful subclassification of atherosclerotic plaque pathology, for risk stratification, and for elucidation of certain of the mechanisms by which effective therapies prevent ischemic events.
